TACR1 and myeloid leukemia: SP, via the NK-1R, promotes weak mitochondrial and intracellular Ca++ fluxes, but NK-1R antagonists (aprepitant, SR-140,333) favor a rapid cytosolic/mitochondria Ca++ elevation in human myeloid leukemia cell lines (Table 1 and Table 2) [1].